Work

Zopapogene imadenovec-drba, a novel non-replicating adenoviral vector-based immunotherapy: Effects on complete and durable responses in recurrent respiratory papillomatosis pivotal trial.

Year: 2026

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2026.44.16_suppl.6104

Authors: Scott Norberg, James L. Gulley, Jeffrey Schlom, Gaetano Bonifacio, Roshanak Semnani, Tasha Tan, David M. Dalton, Premkumar Giridhar, Amy Lankford, Douglas E. Brough, Rutul R. Shah, Helen Sabzevari, Clint Allen

Institutions: National Institutes of Health, National Cancer Institute, Center for Cancer Research

Language: English

Topic: Virus-based gene therapy research

Subfield: Genetics

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W7162565523

Cites:

Cited by: 1

Related to: